Taxol®: The First Microtubule Stabilizing Agent
- PMID: 28792473
- PMCID: PMC5578123
- DOI: 10.3390/ijms18081733
Taxol®: The First Microtubule Stabilizing Agent
Abstract
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent described in the literature. This short review of the mechanism of action of Taxol® emphasizes the research done in the Horwitz' laboratory. It discusses the contribution of photoaffinity labeled analogues of Taxol® toward our understanding of the binding site of the drug on the microtubule. The importance of hydrogen/deuterium exchange experiments to further our insights into the stabilization of microtubules by Taxol® is addressed. The development of drug resistance, a major problem that arises in the clinic, is discussed. Studies describing differential drug binding to distinct β-tubulin isotypes are presented. Looking forward, it is suggested that the β-tubulin isotype content of a tumor may influence its responses to Taxol®.
Keywords: Taxol®; drug binding site; drug resistance; photoaffinity labeling; tubulin isotypes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971;93:2325–2327. - PubMed
-
- Chabner B.A. Taxol. In: DeVita V.T. Jr., Lawrence T.S., Rosenberg S.A., editors. Principles and Practice of Oncology. 3rd ed. Volume 5. J.B. Lippincott Company; Philadelphia, PA, USA: 1991. pp. 1–10.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources